Peripheral Intravenous Catheters Market Size & Forecasts 2026-2035, By Segments (Product, Technology, Lumen, End-use), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Becton Dickinson, B. Braun, Smiths Medical, Terumo, Teleflex)

Market Outlook

Peripheral Intravenous Catheters Market size is expected to advance from USD 6.16 billion in 2025 to USD 13.05 billion by 2035, registering a CAGR of more than 7.8% across 2026-2035. By 2026, the industry is anticipated to generate USD 6.58 billion in revenue.

• Base Year Value (2025): USD 6.16 Billion
• CAGR (2026-2035): 7.8%
• Forecast Year Value (2035): USD 13.05 Billion
• Historical Data Period: 2021-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Key Takeaways

• North America region possessed more than 41.2% market share in 2025, attributed to advanced hospital and outpatient care.
• Asia Pacific region will observe around 9% CAGR between 2026 and 2035, on account of growing surgical and infusion therapy needs.
• With a share of 66.64% in 2025, short PIVC segment’s dominance was secured by ease of insertion and cost-effectiveness.
• Achieving 70.56% peripheral intravenous catheters market share in 2025, the growth of safety PIVC segment was underpinned by focus on reducing needlestick injuries.
• The single lumen segment accounted for 58.8% of the peripheral intravenous catheters market in 2025, driven by widespread use in short-term therapies.
• Leading organizations shaping the peripheral intravenous catheters market include Becton Dickinson (USA), B. Braun (Germany), Smiths Medical (USA), Terumo (Japan), Teleflex (USA), Medtronic (Ireland), Vygon (France), AngioDynamics (USA), Nipro (Japan), ICU Medical (USA).

Market Dynamics

Increasing Hospital Admissions and IV Therapy Usage

The peripheral intravenous catheters market is significantly influenced by the rising rates of hospital admissions and the growing reliance on intravenous (IV) therapy across various medical settings. As healthcare systems respond to increasing patient volumes, particularly in emergency and surgical departments, the demand for efficient and reliable IV access solutions has surged. According to the World Health Organization, the global burden of diseases, including chronic conditions requiring frequent hospital visits, has prompted healthcare providers to optimize patient care through IV therapies. This trend not only enhances treatment efficacy but also opens avenues for established players to expand their product lines and for new entrants to innovate in service delivery, ensuring timely access to essential medical interventions.

Adoption of Safety-Engineered Peripheral Catheters

The shift towards safety-engineered peripheral catheters is reshaping the landscape of the peripheral intravenous catheters market, driven by heightened awareness of needlestick injuries and associated healthcare costs. Regulatory bodies, including the U.S. Food and Drug Administration, have emphasized the importance of safety in medical devices, prompting manufacturers to prioritize innovation in catheter design. For instance, companies like Becton, Dickinson and Company have developed catheters that incorporate safety mechanisms to protect healthcare workers while ensuring patient safety. This focus on safety not only mitigates risks but also enhances the market's attractiveness to healthcare providers, presenting strategic opportunities for both established firms to leverage their R&D capabilities and new entrants to capture niche segments focused on safety innovations.

Technological Advancements in Catheter Materials and Design

Technological advancements in catheter materials and design are pivotal growth drivers in the peripheral intravenous catheters market, fostering improved patient outcomes and operational efficiencies. Innovations such as biocompatible materials and antimicrobial coatings have significantly enhanced the performance and safety profiles of IV catheters. For example, the incorporation of advanced polymers has led to products that reduce the risk of thrombosis and phlebitis, as noted by the Journal of Vascular Access. As healthcare providers increasingly seek to minimize complications associated with IV therapy, these advancements create substantial opportunities for market players to differentiate themselves through superior product offerings. Furthermore, the ongoing evolution in catheter technology is likely to attract investments and partnerships aimed at accelerating the development of next-generation solutions, ensuring sustained growth in this dynamic market.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing hospital admissions and IV therapy usage	2.00%	Short term (≤ 2 yrs)	North America, Europe (spillover: Asia Pacific)	High	Fast
Adoption of safety-engineered peripheral catheters	1.50%	Medium term (2–5 yrs)	Asia Pacific, North America (spillover: MEA)	Medium	Moderate
Technological advancements in catheter materials and design	1.00%	Long term (5+ yrs)	Europe, Asia Pacific (spillover: Latin America)	Low	Slow

Industry Restraints:

Regulatory Compliance Burdens

The stringent regulatory landscape surrounding peripheral intravenous catheters significantly constrains market growth by imposing rigorous standards that manufacturers must meet before their products can be marketed. Compliance with regulations set forth by organizations such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) not only extends the time-to-market but also increases operational costs. For instance, the FDA's recent updates on premarket submissions have necessitated more comprehensive clinical data, leading to delays for companies like B. Braun and Smiths Medical, which must navigate complex approval processes. This regulatory pressure can deter new entrants from investing in the market, thereby stifling innovation and limiting competition, which is crucial for driving advancements in catheter technology.

Supply Chain Vulnerabilities

Supply chain disruptions have emerged as a critical restraint affecting the peripheral intravenous catheters market, particularly in the wake of the COVID-19 pandemic. The reliance on global suppliers for raw materials, such as silicone and plastics, has exposed vulnerabilities that can lead to shortages and increased production costs. For example, manufacturers like Terumo Corporation have reported challenges in sourcing essential components, resulting in delays and impacting their ability to fulfill orders. This fragility not only hampers the operational efficiency of established players but also poses significant barriers for startups attempting to enter the market. As companies strive for resilience in their supply chains, the ongoing geopolitical tensions and sustainability pressures are likely to further complicate procurement strategies, shaping the market dynamics in the foreseeable future.

Regional Forecast

North America Market Statistics:

The North America region represented more than 41.2% of the global peripheral intravenous catheters market in 2025, establishing itself as the largest segment. This dominance is largely attributed to advanced hospital and outpatient care systems, which are increasingly prioritizing patient-centered approaches and high-quality medical solutions. The region's robust healthcare infrastructure, combined with a rising demand for minimally invasive procedures, has driven significant investments in technological advancements and operational efficiencies. Furthermore, shifts in consumer preferences towards enhanced safety and efficacy in medical devices have prompted manufacturers to innovate continuously, thereby strengthening the competitive landscape and ensuring compliance with stringent regulatory standards set by organizations such as the Food and Drug Administration (FDA). The interplay of these dynamics positions North America as a fertile ground for investment opportunities in the peripheral intravenous catheters market, suggesting a promising outlook for stakeholders.

The United States anchors the North American peripheral intravenous catheters market, serving as a pivotal hub for innovation and growth. The country's regulatory environment, characterized by rigorous safety and efficacy standards enforced by the FDA, has propelled manufacturers to enhance product offerings, ensuring they meet the evolving needs of healthcare providers and patients alike. For instance, the increased focus on patient safety has led to the development of advanced catheter technologies that minimize the risk of complications, as highlighted in a report by the Centers for Disease Control and Prevention (CDC). This emphasis on quality aligns with consumer demand for reliable healthcare solutions, further driving market expansion. As such, the U.S. market not only reinforces the regional leadership in peripheral intravenous catheters but also offers significant strategic implications for investors looking to capitalize on the growing healthcare sector in North America.

Asia Pacific Market Analysis:

Asia Pacific emerged as the fastest-growing region in the peripheral intravenous catheters market, registering a robust CAGR of 9%. This growth is primarily driven by the increasing surgical and infusion therapy needs across the region, reflecting a broader trend toward enhanced healthcare services. The rising patient population, coupled with the growing prevalence of chronic diseases, has intensified the demand for effective and efficient intravenous solutions. Furthermore, advancements in catheter technology, such as the development of safety-engineered devices, have aligned with evolving healthcare regulations and patient safety standards, fostering a competitive landscape that encourages innovation and operational excellence. As a result, the region is witnessing significant investments in healthcare infrastructure, which are expected to further bolster market growth and enhance access to advanced medical technologies.

In Japan, the peripheral intravenous catheters market plays a pivotal role, driven by a sophisticated healthcare system and a high demand for advanced medical devices. The growing surgical and infusion therapy needs are evident in the increasing number of surgical procedures and a heightened focus on patient-centered care. Japanese healthcare providers are increasingly adopting safety-engineered catheters, reflecting a commitment to patient safety and compliance with stringent regulatory standards set by the Pharmaceuticals and Medical Devices Agency (PMDA). This shift is supported by a well-established supply chain and a strong emphasis on technological innovation, as seen in the collaborations between local manufacturers like Terumo Corporation and research institutions. Consequently, Japan's advancements in medical technology not only enhance patient care but also position the country as a leader in the Asia Pacific peripheral intravenous catheters market.

China represents another crucial player in the peripheral intravenous catheters market, driven by rapid healthcare reforms and increasing healthcare spending. The demand for peripheral intravenous catheters is surging due to the country's growing surgical and infusion therapy needs, particularly in urban areas where healthcare access is improving. The Chinese government’s initiatives to expand healthcare coverage and invest in modern medical facilities have catalyzed the adoption of advanced intravenous solutions. Local manufacturers, such as Jiangsu Jichuan Medical Technology, are innovating to meet the rising demand, focusing on product quality and compliance with international standards. As a result, China's dynamic healthcare landscape and commitment to enhancing medical service delivery create substantial opportunities for growth in the peripheral intravenous catheters market, reinforcing the region's overall leadership.

Europe Market Trends:

Europe held a commanding share in the peripheral intravenous catheters market, driven by a robust healthcare infrastructure and a growing emphasis on patient safety and quality of care. The region's healthcare systems are increasingly adopting innovative technologies and sustainable practices, reflecting a shift in consumer preferences towards more efficient and environmentally friendly medical solutions. Regulatory frameworks are evolving to enhance safety standards, while advancements in supply chain logistics have improved the availability of high-quality catheters. Notable examples include the European Medicines Agency's commitment to stringent safety regulations, which has spurred manufacturers to innovate. As a result, Europe presents significant opportunities for growth, particularly as healthcare providers seek to enhance patient outcomes and operational efficiencies.

Germany plays a pivotal role in the peripheral intravenous catheters market, characterized by its advanced healthcare technology sector and strong regulatory environment. The country has witnessed moderate growth, driven by increasing investments in healthcare innovation and a growing demand for minimally invasive procedures. The Federal Ministry of Health's initiatives to improve healthcare delivery and patient safety have led to a surge in the adoption of advanced catheter technologies. For instance, companies like B. Braun Melsungen AG are leading the way in developing smart catheters that enhance patient monitoring. This focus on innovation positions Germany as a key player in the regional market, offering strategic advantages for investors looking to tap into emerging healthcare solutions.

France also maintains a substantial share in the peripheral intravenous catheters market, influenced by its commitment to enhancing healthcare access and quality. The country's healthcare reforms have prioritized patient-centric care, which aligns with the increasing demand for safer and more effective intravenous solutions. The French National Authority for Health has been actively promoting the adoption of best practices in catheter use, thereby driving demand for high-quality products. Companies like Fresenius Kabi are responding to this demand with innovative product offerings that cater to the evolving needs of healthcare providers. As France continues to evolve its healthcare policies, it presents a strategic opportunity for stakeholders in the peripheral intravenous catheters market, contributing to the overall growth trajectory in Europe.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Restrictive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Strong	Strong	Moderate	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	High	Low	Low
New Entrants / Startups	Moderate	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Segmentation Analysis

 

Analysis by Product

The peripheral intravenous catheters market for short PIVC dominated the segment with a 66.6% share in 2025, primarily due to its ease of insertion and cost-effectiveness. This segment's leadership is attributed to the increasing demand for simplified procedures in clinical settings, where healthcare professionals prioritize efficiency and patient comfort. The growing trend towards streamlined workflows and reduced operational costs aligns with customer preferences for reliable and affordable solutions. Sources such as the World Health Organization have highlighted the importance of minimizing healthcare expenditures without compromising patient care quality. This segment presents strategic advantages for both established firms and emerging players, especially in developing innovative designs that enhance usability. Given the ongoing advancements in medical technology and the rising focus on patient-centered care, the short PIVC segment is expected to remain relevant in the near to medium term.

Analysis by Technology

The peripheral intravenous catheters market for safety PIVC captured over 70.6% share of the technology segment in 2025, driven by a focus on reducing needlestick injuries. This segment leads due to heightened awareness and regulatory pressures aimed at improving occupational safety in healthcare environments. The increasing incidence of needlestick injuries has prompted healthcare facilities to adopt safer alternatives, with organizations like the Centers for Disease Control and Prevention advocating for the implementation of safety-engineered devices. The safety PIVC segment not only addresses compliance with safety regulations but also aligns with workforce trends prioritizing employee health and safety. This segment creates opportunities for established manufacturers to innovate while enabling new entrants to capture market share through unique offerings. With ongoing technological advancements and a commitment to enhancing patient and provider safety, the safety PIVC segment is poised for sustained relevance in the evolving healthcare landscape.

Analysis by Lumen

The peripheral intravenous catheters market for single lumen PIVC represented more than 58.8% of the lumen segment in 2025, attributed to its widespread use in short-term therapies. This segment's dominance stems from its adaptability and effectiveness in various clinical scenarios, where simplicity and reliability are paramount. The increasing prevalence of outpatient procedures and short-term treatments has driven demand for single lumen catheters, as healthcare providers seek efficient solutions that minimize patient discomfort. The American Society of Health-System Pharmacists has noted the importance of selecting appropriate catheter types based on clinical needs, further supporting the single lumen's position. This segment offers significant strategic advantages to both established players and newcomers, particularly in developing specialized products that cater to specific therapeutic needs. As healthcare continues to evolve with a focus on outpatient care and rapid recovery protocols, the single lumen segment is expected to maintain its significance in the market.

Report Segmentation
Segment	Sub-Segment
Product	Short PIVC, Integrated/closed PIVC
Technology	Conventional PIVC, Safety PIVC
Lumen	Single lumen, Double lumen, Multi-lumen
End-use	Hospitals, Ambulatory surgical centers, Other end-users

Competitive Landscape

Key players in the peripheral intravenous catheters market include Becton Dickinson, B. Braun, Smiths Medical, Terumo, Teleflex, Medtronic, Vygon, AngioDynamics, Nipro, and ICU Medical. Each of these companies holds a significant position, leveraging their extensive experience and innovation capabilities to dominate the market. Becton Dickinson, for instance, is recognized for its advanced technology and vast distribution network, while B. Braun emphasizes quality and safety in its product offerings. Smiths Medical and Teleflex are noted for their commitment to enhancing patient care through innovative solutions, whereas Medtronic and Terumo focus on integrating cutting-edge technology into their catheter designs, thus influencing industry standards and practices. The prominence of these players is further underscored by their established reputations and robust product portfolios that cater to diverse healthcare needs.

The competitive landscape of the peripheral intravenous catheters market is characterized by dynamic strategic maneuvers among the leading companies. Collaborative efforts and technological advancements have become pivotal as firms seek to enhance their market positioning and drive innovation. For instance, several players have engaged in partnerships to expand their product lines and improve patient outcomes through enhanced catheter designs. Moreover, the introduction of new products that incorporate advanced materials and smart technologies reflects a collective focus on addressing clinical challenges and improving user experience. This ongoing evolution is indicative of a competitive environment where agility and responsiveness to market demands are crucial for sustaining growth and relevance in the sector.

Strategic / Actionable Recommendations for Regional Players

In North America, fostering relationships with technology firms specializing in healthcare innovations could enhance product offerings, particularly in smart catheter technologies. Engaging in partnerships with hospitals and healthcare systems may also facilitate the adoption of new solutions, thereby improving market penetration.

In the Asia Pacific region, focusing on high-growth sub-segments such as pediatric or geriatric care can provide opportunities for tailored product development. Collaborating with local healthcare providers to understand specific regional needs can drive innovation and customer loyalty.

For Europe, leveraging regulatory frameworks to expedite the introduction of innovative catheter solutions could strengthen competitive positioning. Establishing alliances with research institutions may also enhance R&D capabilities, enabling players to respond effectively to evolving market demands and technological advancements.